Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The tested hair dye ingredients do not form harmful oxidized metabolites in the liver.

The new testosterone patch works as well as the gel.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Metformin helps lab-grown skin and hair cells work better to create hair.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

A simple and eco-friendly method was developed to make finasteride Form-I using water.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

The compound was successfully made and shows potential for treating prostate cancer.

Niosomes can effectively deliver cetirizine topically for treating alopecia.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

A new method using NBD-CL can accurately and precisely measure finasteride in medicine, and could be used regularly for quality control in the industry.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

GD-23 reduces anxiety by relying on neurosteroid production.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.